Attributes | Values |
---|
rdf:type
| |
Description
| - Background: Macrophage inhibitory cytokine-1 (MIC-1) has recently been associated with markers of heart function. Aim: This study sought to verify the relationship between markers of heart function (New York Heart Association classification (NYHA)): left ventricle ejection fraction (LVEF), N terminal prohormone of natriuretic peptide B type (NT-proBNP) and MIC-1. Furthermore, the assessment of the usefulness of these markers for differential diagnosis of the myocardial form of dyspnea was explored. Methods: 124 patients (65 women and 59 men) were examined for dyspnea without signs of acute coronary syndrome. All patients underwent echocardiography (calculation of left ventricle ejection fraction-LVEF), and serum NT-proBNP and MIC-1 were determined. 21 healthy individuals were defined as the control group. Results and discussion: Patients were divided into two groups: A-individuals with non-cardiogenic form of dyspnea, n = 77 and B-individuals with cardiogenic ethiology of dyspnea, n = 47. Significant
- Background: Macrophage inhibitory cytokine-1 (MIC-1) has recently been associated with markers of heart function. Aim: This study sought to verify the relationship between markers of heart function (New York Heart Association classification (NYHA)): left ventricle ejection fraction (LVEF), N terminal prohormone of natriuretic peptide B type (NT-proBNP) and MIC-1. Furthermore, the assessment of the usefulness of these markers for differential diagnosis of the myocardial form of dyspnea was explored. Methods: 124 patients (65 women and 59 men) were examined for dyspnea without signs of acute coronary syndrome. All patients underwent echocardiography (calculation of left ventricle ejection fraction-LVEF), and serum NT-proBNP and MIC-1 were determined. 21 healthy individuals were defined as the control group. Results and discussion: Patients were divided into two groups: A-individuals with non-cardiogenic form of dyspnea, n = 77 and B-individuals with cardiogenic ethiology of dyspnea, n = 47. Significant (en)
|
Title
| - Macrophage-inhibitory cytokine-1 (MIC-1) in differential diagnosis of dyspnea - a pilot study
- Macrophage-inhibitory cytokine-1 (MIC-1) in differential diagnosis of dyspnea - a pilot study (en)
|
skos:prefLabel
| - Macrophage-inhibitory cytokine-1 (MIC-1) in differential diagnosis of dyspnea - a pilot study
- Macrophage-inhibitory cytokine-1 (MIC-1) in differential diagnosis of dyspnea - a pilot study (en)
|
skos:notation
| - RIV/62157124:16370/09:00002101!RIV10-MSM-16370___
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/62157124:16370/09:00002101
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - MIC-1; ELISA; Dyspnea; Heart failure (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - GB - Spojené království Velké Británie a Severního Irska
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| |
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Stejskal, David
- Karpíšek, Michal
- Švesták, Marek
- Humeňanský, Viera
- Lačňák, Bořek
|
http://linked.open...ain/vavai/riv/wos
| |
issn
| |
number of pages
| |
http://localhost/t...ganizacniJednotka
| |
is http://linked.open...avai/riv/vysledek
of | |